D_Purchase Description.pdf
PDF 145 KB Posted
- Attached to
- Ingenuity Pathway Analysis – IPA Analysis Match Explorer CL – Software Federal contract opportunity
- Solicitation number
- 75N95023Q00200
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| D_FAR 52.212-5 (Mar 2023).pdf | ||
| D_FAR 52.204-26 Oct 2020.pdf | ||
| D_FAR 52.204-24 Nov 2021.pdf | ||
| D_Invoicing Instructions With IPP 3-23.pdf |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Version 11-30-2016-1 FAR Part 11—Describing Agency Needs
PURCHASE DESCRIPTION
1. Statement of Need and Purpose: Ingenuity Pathway Analysis – one institute-wide floating annual license – IPA Analysis Match Explorer CL – Qiagen Software.
2. Background Information and Objective: Aging and age-related diseases are caused by complex interplay of many different factors. To better understand the cause-effect relationship, the finding of high-throughput assays such as RNA sequencing or microarray needs to be looked at in the context of biological processes and pathways.
The Ingenuity Pathway Analysis software is an all-in-one, web-based software application that enables researchers to analyze, integrate, and understand data derived from gene expression, microRNA, and SNP microarrays; phosphoproteomics, metabolomics, proteomics, and RNA-Seq experiments; and small-scale experiments that generate gene and chemical lists. The IPA software will help the researchers to look at altered biological processes and pathways.
3. Generic Name of Product: Ingenuity Pathway Analysis - IPA Analysis Match Explorer CL
4. Purchase Description:
Product Name Product Code Quantity Term (months) Start Date End Date
IPA Analysis Match Explorer CL 836506 1 12.00 May 17, 2023 May 16, 2024
5. Salient characteristics: IPA is an all-in-one, web-based software application that enables researchers to analyze, integrate, and understand data derived from gene expression, microRNA, and SNP microarrays; phosphoproteomics, metabolomics, proteomics, and RNA-Seq experiments; and small-scale experiments that generate gene and chemical lists.
6. Quantity: 1 license
7. Delivery Date: N/A
8. Period of Performance: May 17, 2023-May 16, 2024 (base)
9. Option(s): May 17, 2024-May 16, 2025 (Option Period One) May 17, 2025-May 16, 2026 (Option Period Two)
File details come from the government source that posted it. Updated .